Skip to main content
Toggle navigation
FR
EN
Drupal
Main navigation EN
About Crossject
Who we are
Governance
R&D
Our technology
ZENEO®: needle-free technology
Products under development
Our supply chain
Therapeutic areas
Migraines and cluster headaches
Anaphylactic shock
Acute adrenal crisis
Epileptic seizure
Opioid overdose
Rheumatoid arthritis
Severe asthma crisis
Main navigation 2 EN
Finances
Profile
Analyst coverage
Financial releases
News
Our news
Press releases
Careers
Working at Crossject
Available position and applications
Contact
Search
Search
Enter the terms you wish to search for.
Home
Finances
First-half 2022 results Achievement of major milestones in the first half On track for a change of dimension
First-half 2022 results Achievement of major milestones in the first half On track for a change of dimension
Image
Date de parution
2022/09/22
PDF du document
Crossject_Résultats semestriels 2022 et point d'activité vdefinitive ENG .pdf
348.85 KB
